AR009137A1 - Derivados de acidos 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasas de matriz, composicion farmaceutica y uso dedichos derivados para preparar dedicametos. - Google Patents
Derivados de acidos 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasas de matriz, composicion farmaceutica y uso dedichos derivados para preparar dedicametos.Info
- Publication number
- AR009137A1 AR009137A1 ARP970105054A ARP970105054A AR009137A1 AR 009137 A1 AR009137 A1 AR 009137A1 AR P970105054 A ARP970105054 A AR P970105054A AR P970105054 A ARP970105054 A AR P970105054A AR 009137 A1 AR009137 A1 AR 009137A1
- Authority
- AR
- Argentina
- Prior art keywords
- carbon atoms
- derivatives
- heteroaryl
- aryl
- ring
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000007513 acids Chemical group 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 8
- 125000005842 heteroatom Chemical group 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000004429 atom Chemical group 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- -1 1,2-naphthalenedicarboximidoyl Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical class 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003475 metalloproteinase inhibitor Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Indole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Derivados de ácidos 4-bifenil-4-hidroxibutírico sustituídos como e inhibidores de metaloproteasas de matriz que tiene la formula general(figura 1) donde: T es un grupo sustituyente farmacéuticamente aceptable; X es 0, 1 o 2; m es 0 o unint egro de 1-4; n es 0 o 1; y o bien A y G son ambos CH2;o A es un enlace químico y G es CH o N; y G es CH; y A está conectado a G mediante un enlace formador de anillo que tiene la formula (CH2)0-3(Q)(CH2)0-3;donde Q es un enlace químico, Su O y C, S y O constituyen átomos de enlace; se dan como resultado la formacion de un anillo que incluye A, dicho enlaceformador de anillo y G; con las condiciones de que la suma de n más la cantidad de total de átomos de enlace en dicho enlaceformador d e anillo es un entero dedesde 1 a 4 y la cantidad de heteroatomos en dicho anillo es de 0 o 1; R1 es arilo de 6-10 carbonos, con la condicion de que si este grupo arilo es fenilo,entonces X es uno o dos, heteroarilo que comprende 4-9átomos de car bono y por lo menos un heteroátomo N, O, o S, alquenilo arilo-sustituido donde la porcionarilo contiene 6-20 átomos de carbono y la porcion alquenilo contiene 2-5 átomos de carbonos; alquenilo heteroarilo-sustituido donde laporcionheteroarilo comprende 4-9 átomos de carbono y por lo menos un heteroátomo N, O o S, y la porcion alquenilo contiene 2-5 átomos de carbono, alquenilo arilo-sustituido donde la porcion arilo contiene 6-10 átomos de carbono y la porcionalquenilo contiene 2-5 át omos de carbono, alquenilo heteroarilo-sustituídodonde la porcion heteroarilo comprende 4-9 átomos de carbono y por lo menos un N, O o S heteroátomo y la porcion alquenilo contiene 2-5 átomos de carbono,N-ftalimidoilo,N-(1,2-naftalendicarboximidoil o), N-(2,3- -naftalendicarboximidoilo); N-indoilo, N-(2-pirroldinonilo); N-maleimidoilo
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3026496P | 1996-10-31 | 1996-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR009137A1 true AR009137A1 (es) | 2000-03-08 |
Family
ID=21853363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105054A AR009137A1 (es) | 1996-10-31 | 1997-10-30 | Derivados de acidos 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasas de matriz, composicion farmaceutica y uso dedichos derivados para preparar dedicametos. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5939583A (es) |
| EP (1) | EP0937036B1 (es) |
| JP (1) | JP2001505877A (es) |
| KR (1) | KR20000052899A (es) |
| CN (1) | CN1140508C (es) |
| AR (1) | AR009137A1 (es) |
| AT (1) | ATE210112T1 (es) |
| AU (1) | AU731830B2 (es) |
| BG (1) | BG63159B1 (es) |
| BR (1) | BR9712707A (es) |
| CA (1) | CA2268770A1 (es) |
| CZ (1) | CZ148599A3 (es) |
| DE (1) | DE69708909T2 (es) |
| DK (1) | DK0937036T3 (es) |
| EE (1) | EE03745B1 (es) |
| ES (1) | ES2167021T3 (es) |
| HU (1) | HUP9904664A3 (es) |
| ID (1) | ID18712A (es) |
| IL (1) | IL129420A (es) |
| MY (1) | MY117687A (es) |
| NO (1) | NO312629B1 (es) |
| PL (1) | PL333112A1 (es) |
| PT (1) | PT937036E (es) |
| SK (1) | SK58399A3 (es) |
| TR (1) | TR199900945T2 (es) |
| TW (1) | TW464642B (es) |
| UA (1) | UA57047C2 (es) |
| WO (1) | WO1998022436A1 (es) |
| ZA (1) | ZA979756B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2780402B1 (fr) * | 1998-06-30 | 2001-04-27 | Adir | Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| CA2356053A1 (en) | 1998-12-30 | 2000-07-13 | Bayer Aktiengesellschaft | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| EP1031349A1 (en) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
| DE10058163C2 (de) * | 2000-11-22 | 2003-07-10 | Bebig Isotopen Und Medizintech | Verfahren und Applikator zum Positionieren und/oder Auswerfen von Strahlenquellen über Hohlnadeln in biologisches Gewebe |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| JP2006516548A (ja) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
| US8460243B2 (en) | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
| US7722536B2 (en) | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
| CA2858901C (en) | 2004-06-04 | 2024-01-16 | Carolyn Anderson | Diabetes care host-client architecture and data management system |
| MX2007010185A (es) * | 2005-02-22 | 2007-12-06 | Ranbaxy Lab Ltd | Derivados de acido 5-fenil-pentanoico como inhibidores de metaloproteinasa de matriz para el tratamiento de asma y otras enfermedades. |
| US7414142B2 (en) | 2005-09-19 | 2008-08-19 | Wyeth | 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators |
| US7319152B2 (en) | 2005-09-19 | 2008-01-15 | Wyeth | 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators |
| EP2014647A4 (en) * | 2006-04-17 | 2010-09-08 | Sumitomo Chemical Co | Process for producing polycyclic lactam |
| JP5399902B2 (ja) * | 2006-08-22 | 2014-01-29 | ランバクシー ラボラトリーズ リミテッド | マトリックスメタロプロテイナーゼ阻害剤 |
| US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| JP6804352B2 (ja) * | 2017-03-22 | 2020-12-23 | 大阪瓦斯株式会社 | コラゲナーゼｍｍｐ１及び３の産生抑制剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1040735A (en) * | 1964-07-23 | 1966-09-01 | British Drug Houses Ltd | 4-aryl-3-hydroxybutyric acid and esters, amides and salts thereof |
| US4021479A (en) * | 1971-03-17 | 1977-05-03 | Boehringer Ingelheim Gmbh | Derivatives of 4-(4-biphenylyl)-butyric acid |
| ES446581A1 (es) * | 1975-04-04 | 1977-06-16 | Boots Co Ltd | Un procedimiento para preparar acidos 2-arilpropionicos. |
| US4151302A (en) * | 1975-06-28 | 1979-04-24 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Araliphatic dihalogen compounds composition and method of use |
| US4168385A (en) * | 1975-09-25 | 1979-09-18 | American Cyanamid Company | Hypolipemic phenylacetic acid derivatives |
| US4567289A (en) * | 1979-08-17 | 1986-01-28 | Merck & Co., Inc. | Substituted pyranone inhibitors of cholesterol synthesis |
| JPS60169462A (ja) * | 1984-02-15 | 1985-09-02 | Sumitomo Chem Co Ltd | 光学活性なフエニルセリン誘導体の製造法 |
| CA1223602A (en) * | 1983-05-25 | 1987-06-30 | Naohito Ohashi | Process for producing 3-(3,4-dihydroxyphenyl) serine |
| US4855321A (en) * | 1986-01-31 | 1989-08-08 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US5001128A (en) * | 1987-12-21 | 1991-03-19 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | HMG-COA reductase inhibitors |
| US5393780A (en) * | 1993-03-26 | 1995-02-28 | Fujirebio Inc. | 4-fluorobiphenyl derivatives |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
-
1997
- 1997-10-29 MY MYPI97005143A patent/MY117687A/en unknown
- 1997-10-30 DE DE69708909T patent/DE69708909T2/de not_active Expired - Fee Related
- 1997-10-30 ES ES97945585T patent/ES2167021T3/es not_active Expired - Lifetime
- 1997-10-30 AU AU51024/98A patent/AU731830B2/en not_active Ceased
- 1997-10-30 BR BR9712707-8A patent/BR9712707A/pt unknown
- 1997-10-30 PT PT97945585T patent/PT937036E/pt unknown
- 1997-10-30 WO PCT/US1997/019960 patent/WO1998022436A1/en not_active Ceased
- 1997-10-30 PL PL97333112A patent/PL333112A1/xx unknown
- 1997-10-30 SK SK583-99A patent/SK58399A3/sk unknown
- 1997-10-30 AR ARP970105054A patent/AR009137A1/es unknown
- 1997-10-30 JP JP52367798A patent/JP2001505877A/ja active Pending
- 1997-10-30 DK DK97945585T patent/DK0937036T3/da active
- 1997-10-30 EP EP97945585A patent/EP0937036B1/en not_active Expired - Lifetime
- 1997-10-30 IL IL12942097A patent/IL129420A/xx not_active IP Right Cessation
- 1997-10-30 CZ CZ991485A patent/CZ148599A3/cs unknown
- 1997-10-30 ZA ZA9709756A patent/ZA979756B/xx unknown
- 1997-10-30 US US08/960,921 patent/US5939583A/en not_active Expired - Fee Related
- 1997-10-30 CA CA002268770A patent/CA2268770A1/en not_active Abandoned
- 1997-10-30 UA UA99052950A patent/UA57047C2/uk unknown
- 1997-10-30 CN CNB971809100A patent/CN1140508C/zh not_active Expired - Fee Related
- 1997-10-30 KR KR1019990703763A patent/KR20000052899A/ko not_active Ceased
- 1997-10-30 AT AT97945585T patent/ATE210112T1/de not_active IP Right Cessation
- 1997-10-30 EE EEP199900180A patent/EE03745B1/xx not_active IP Right Cessation
- 1997-10-30 TR TR1999/00945T patent/TR199900945T2/xx unknown
- 1997-10-30 HU HU9904664A patent/HUP9904664A3/hu unknown
- 1997-10-30 TW TW086116305A patent/TW464642B/zh not_active IP Right Cessation
- 1997-10-31 ID IDP973569A patent/ID18712A/id unknown
-
1999
- 1999-04-27 NO NO19991994A patent/NO312629B1/no not_active IP Right Cessation
- 1999-05-21 BG BG103426A patent/BG63159B1/bg unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR009137A1 (es) | Derivados de acidos 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasas de matriz, composicion farmaceutica y uso dedichos derivados para preparar dedicametos. | |
| TR199801594A2 (xx) | CCR-3 resept�r antagonistleri. | |
| EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
| EA200200253A1 (ru) | Ингибиторы клеточной адгезии | |
| YU11997A (sh) | Laktamski derivati i njihove farmaceutske kompozicije | |
| PA8439101A1 (es) | Lactamas e imidas heterociclicas de aralquilo y aralquilideno | |
| YU40997A (sh) | Novi oksadiazoli, postupci za njihovo pripremanje | |
| TR199900920T2 (xx) | Nafthiridin t�revleri. | |
| TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
| CY1112274T1 (el) | Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν | |
| DK1169298T3 (da) | Farmaceutiske forbindelser | |
| TR199901578T2 (xx) | Klaritromisin form 0 kristali | |
| ES2174298T3 (es) | Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| TR199900501T2 (xx) | Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�. | |
| ATE276744T1 (de) | Neutrale-kationische lipide zur verabreichung von nukleinesäuren und arzneimitteln | |
| DE69924292D1 (de) | Pyrazol verbindungen und ihre verwendung | |
| EA200100516A1 (ru) | Производные 3,3-биарилпиперидина и 2,2-биарилморфолина | |
| EA200000431A3 (ru) | Новые замещенные димерные соединения, способ их получения и фармацевтические композиции, содержащие их | |
| TR199801039T2 (xx) | Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul. | |
| TR200200125T2 (tr) | Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar. | |
| YU44301A (sh) | 5ht1 antagonisti za antidepresantnu terapiju | |
| DK0879231T3 (da) | Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler | |
| EA200000522A1 (ru) | 5-htагонисты | |
| DK0904270T3 (da) | Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler | |
| BR9707342A (pt) | Dihidrobensofurano e compostos correlatod úteis como agentes antiinflamatórios |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |